Iovance Biotherapeutics

5 open remote positions

Iovance Biotherapeutics is a biotechnology company pioneering tumor infiltrating lymphocyte (TIL) therapy for cancer patients. The company is a clinical-stage organization with a strong focus on innovation and collaboration in a fast-paced environment.

Salary Distribution 4 of 5 jobs

Open Positions

$90,000–$100,000/yr

  • Support GCP/GCLP/GVP audits for investigational sites, internal systems, and clinical service providers, including planning, coordination, and reporting.
  • Assist with commercial inspections, inspection readiness activities, and GCP compliance tasks such as investigations and change controls.
  • Maintain a continuous improvement mindset and represent the Clinical Quality Assurance Team in cross-functional projects.

$145,000–$160,000/yr

  • Manage end-to-end patient cases for TIL therapy from referral through post-infusion, serving as a primary contact and trusted advisor.
  • Collaborate with treatment centers, interdisciplinary care teams, and internal partners to coordinate tumor procurement, manufacturing, and time-sensitive milestones.
  • Identify and resolve barriers to therapy access, track critical milestones, and contribute to continuous improvement and site onboarding best practices.

$350,000–$380,000/yr

  • Build and lead the US Field Medical Affairs organization, including hiring and managing a high-performing MSL team.
  • Implement field strategy in alignment with clinical development and launch plans, and oversee MSL training and analytics.
  • Collaborate internally and externally, track KPIs, and ensure compliance with regulations while engaging key opinion leaders.

$220,000–$250,000/yr

  • Lead global regulatory strategy for one or more drug development programs, with emphasis on submissions and health authority interactions.
  • Plan, manage, and create Clinical Trial Applications, Market Applications, and amendments, ensuring high-quality documents.
  • Collaborate with cross-functional teams to create and negotiate clinical-regulatory development paths and prepare for health authority meetings.